Answer
IVEMEND (fosaprepitant dimeglumine) should be used with caution in patients with moderate to severe liver impairment because data are limited in moderate impairment and absent in severe impairment.
Sources for this answer
- IVEMEND 150 mg powder for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 16Document updated
Sources checked